Found: 18
Select item for more details and to access through your institution.
Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus.
- Published in:
- Nature Medicine, 2000, v. 6, n. 7, p. 821, doi. 10.1038/77558
- By:
- Publication type:
- Article
Characterizing Cellular Responses During Oncolytic Maraba Virus Infection.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 3, p. 580, doi. 10.3390/ijms20030580
- By:
- Publication type:
- Article
Spatial and temporal epithelial ovarian cancer cell heterogeneity impacts Maraba virus oncolytic potential.
- Published in:
- 2017
- By:
- Publication type:
- journal article
High-throughput screening to enhance oncolytic virus immunotherapy.
- Published in:
- Oncolytic Virotherapy, 2016, v. 5, p. 15, doi. 10.2147/OV.S66217
- By:
- Publication type:
- Article
Development and applications of oncolytic Maraba virus vaccines.
- Published in:
- Oncolytic Virotherapy, 2018, v. 7, p. 117, doi. 10.2147/OV.S154494
- By:
- Publication type:
- Article
Maraba MG1 Virus Enhances Natural Killer Cell Function via Conventional Dendritic Cells to Reduce Postoperative Metastatic Disease.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 7, p. 1320, doi. 10.1038/mt.2014.60
- By:
- Publication type:
- Article
Maraba Virus as a Potent Oncolytic Vaccine Vector.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 2, p. 420, doi. 10.1038/mt.2013.249
- By:
- Publication type:
- Article
Triptolide-Mediated Inhibition of Interferon Signaling Enhances Vesicular Stomatitis Virus-Based Oncolysis.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 11, p. 2043, doi. 10.1038/mt.2013.187
- By:
- Publication type:
- Article
Harnessing Oncolytic Virus-mediated Antitumor Immunity in an Infected Cell Vaccine.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 9, p. 1791, doi. 10.1038/mt.2012.128
- By:
- Publication type:
- Article
Type I IFN blockade uncouples immunotherapy-induced antitumor immunity and autoimmune toxicity.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Model-based rational design of an oncolytic virus with improved therapeutic potential.
- Published in:
- Nature Communications, 2013, v. 4, n. 6, p. 1974, doi. 10.1038/ncomms2974
- By:
- Publication type:
- Article
Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 422, p. 1, doi. 10.1126/scitranslmed.aao1641
- By:
- Publication type:
- Article
Big Data Offers Novel Insights for Oncolytic Virus Immunotherapy.
- Published in:
- Viruses (1999-4915), 2016, v. 8, n. 2, p. 45, doi. 10.3390/v8020045
- By:
- Publication type:
- Article
Oncolytic Vaccinia virus safely and effectively treats skin tumors in mouse models of xeroderma pigmentosum.
- Published in:
- International Journal of Cancer, 2013, v. 132, n. 3, p. 726, doi. 10.1002/ijc.27695
- By:
- Publication type:
- Article
Identification of Genetically Modified Maraba Virus as an Oncolytic Rhabdovirus.
- Published in:
- Molecular Therapy, 2010, v. 18, n. 8, p. 1440, doi. 10.1038/mt.2010.103
- By:
- Publication type:
- Article
Targeted Inflammation During Oncolytic Virus Therapy Severely Compromises Tumor Blood Flow.
- Published in:
- Molecular Therapy, 2007, v. 15, n. 9, p. 1686, doi. 10.1038/sj.mt.6300215
- By:
- Publication type:
- Article
Carrier Cell-based Delivery of an Oncolytic Virus Circumvents Antiviral Immunity.
- Published in:
- Molecular Therapy, 2007, v. 15, n. 1, p. 123, doi. 10.1038/sj.mt.6300039
- By:
- Publication type:
- Article
Going viral with cancer immunotherapy.
- Published in:
- Nature Reviews Cancer, 2014, v. 14, n. 8, p. 559, doi. 10.1038/nrc3770
- By:
- Publication type:
- Article